Summary:
This study will evaluate the efficacy and safety of basal Insulin Glargine and the GLP-1 in patients with type 2 Diabetes mellitus not sufficiently controlled on oral anti-diabetic druge.g victoza, byetta etc.
Participant should be on
Metformin, ±Pioglitazone PLus Victoza/byetta/Bydureon /Tanzeum /Eperzan or Trulicity
Qualified Participants May Receive:
Trial Medication,
supplies,
Physical By Family Pysician, and
Compensation if you qualify.